Development of new scores for atherosclerotic cardiovascular disease using specific medical examination items: the

Ahmed Arafa1,2, Rena Kashima1,3, Yuka Yasui1,4

  • 1Department of Preventive Cardiology, National Cerebral and Cardiovascular Center.

Insights

New Suita risk models predict stroke, coronary heart disease (CHD), and atherosclerotic cardiovascular disease (ASCVD) using Japanese health check-up data. These models and simple scores aid in estimating 10-year cardiovascular event risk.

Area of Science:

  • Cardiovascular epidemiology
  • Public health
  • Preventive medicine

Background:

  • Previous Suita Study risk models for stroke, CHD, and CVD had limitations for national application due to differing risk factors from Japanese health check-ups.
  • A need existed for updated risk models aligned with data collected during routine Japanese governmental health examinations (Tokutei-Kenshin).

Purpose of the Study:

  • To develop and validate new risk models for predicting stroke, CHD, and atherosclerotic cardiovascular disease (ASCVD) in the Japanese population.
  • To ensure the new models utilize risk factors consistent with those assessed in Japanese national health check-ups.
  • To create simple risk scores for estimating 10-year incidence of these cardiovascular events.

Main Methods:

  • Utilized data from 7,413 participants (aged 30-84) initially free of stroke and CHD, including baseline health examinations and lifestyle questionnaires.
  • Employed multivariable-adjusted Cox regression to identify risk factors for stroke, CHD, and ASCVD (defined as cerebral infarction or CHD).
  • Assessed model performance using C-statistics for discrimination and Hosmer-Lemeshow tests for calibration, developing 0-100 risk scores.

Main Results:

  • Over 110,428 person-years, 410 stroke, 288 CHD, and 527 ASCVD events occurred.
  • Key risk factors identified include age, smoking, hypertension, diabetes, lipid profiles (HDL, LDL), and urinary protein levels.
  • Risk models demonstrated strong performance (C-statistics >0.750) and good calibration (p-values >0.30), with distinct 10-year incidence rates across different risk score categories.

Conclusions:

  • Successfully developed new Suita risk models for stroke, CHD, and ASCVD incorporating variables from Japanese governmental health check-ups.
  • Created practical risk scores to predict the 10-year likelihood of experiencing stroke, CHD, and ASCVD events.
  • These updated models and scores facilitate more accurate cardiovascular risk assessment in the Japanese population using routinely collected health data.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
19
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
11
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
347
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
9
Assessment of blood pressure in brachial artery(two-step method)01:23

Assessment of blood pressure in brachial artery(two-step method)

Measuring blood pressure is a fundamental skill in healthcare that aids in diagnosing and monitoring hypertension and other cardiovascular conditions. An aneroid sphygmomanometer, commonly used in clinical settings, offers a manual and precise method for blood pressure measurement. The technique for using this instrument involves specific steps that must be carefully executed to ensure accuracy. The following detailed description outlines a two-step technique for assessing blood pressure using...
726
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11